National Vision (EYE) Competitors $26.60 -0.32 (-1.19%) Closing price 09/22/2025 04:00 PM EasternExtended Trading$26.70 +0.10 (+0.39%) As of 07:20 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrendsBuy This Stock EYE vs. NVST, IRTC, BLCO, GKOS, TMDX, LIVN, SLNO, WRBY, INSP, and LQDAShould you be buying National Vision stock or one of its competitors? The main competitors of National Vision include Envista (NVST), iRhythm Technologies (IRTC), Bausch + Lomb (BLCO), Glaukos (GKOS), TransMedics Group (TMDX), LivaNova (LIVN), Soleno Therapeutics (SLNO), Warby Parker (WRBY), Inspire Medical Systems (INSP), and Liquidia Technologies (LQDA). These companies are all part of the "medical equipment" industry. National Vision vs. Its Competitors Envista iRhythm Technologies Bausch + Lomb Glaukos TransMedics Group LivaNova Soleno Therapeutics Warby Parker Inspire Medical Systems Liquidia Technologies National Vision (NASDAQ:EYE) and Envista (NYSE:NVST) are both mid-cap medical equipment companies, but which is the better investment? We will compare the two businesses based on the strength of their analyst recommendations, earnings, risk, dividends, media sentiment, profitability, institutional ownership and valuation. Is EYE or NVST more profitable? Envista has a net margin of 2.11% compared to National Vision's net margin of -0.75%. Envista's return on equity of 4.84% beat National Vision's return on equity.Company Net Margins Return on Equity Return on Assets National Vision-0.75% 3.56% 1.49% Envista 2.11%4.84%2.68% Which has stronger earnings & valuation, EYE or NVST? National Vision has higher earnings, but lower revenue than Envista. National Vision is trading at a lower price-to-earnings ratio than Envista, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioNational Vision$1.82B1.16-$28.50M-$0.18-147.78Envista$2.51B1.38-$1.12B$0.3265.32 Do analysts prefer EYE or NVST? National Vision presently has a consensus price target of $24.73, indicating a potential downside of 7.04%. Envista has a consensus price target of $20.92, indicating a potential upside of 0.10%. Given Envista's higher possible upside, analysts clearly believe Envista is more favorable than National Vision.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score National Vision 0 Sell rating(s) 4 Hold rating(s) 6 Buy rating(s) 0 Strong Buy rating(s) 2.60Envista 1 Sell rating(s) 10 Hold rating(s) 4 Buy rating(s) 1 Strong Buy rating(s) 2.31 Does the media prefer EYE or NVST? In the previous week, National Vision had 3 more articles in the media than Envista. MarketBeat recorded 9 mentions for National Vision and 6 mentions for Envista. National Vision's average media sentiment score of 0.93 beat Envista's score of 0.61 indicating that National Vision is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment National Vision 4 Very Positive mention(s) 2 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Envista 3 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive Which has more risk and volatility, EYE or NVST? National Vision has a beta of 1.23, meaning that its stock price is 23% more volatile than the S&P 500. Comparatively, Envista has a beta of 0.99, meaning that its stock price is 1% less volatile than the S&P 500. SummaryEnvista beats National Vision on 9 of the 15 factors compared between the two stocks. Get National Vision News Delivered to You Automatically Sign up to receive the latest news and ratings for EYE and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding EYE and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart EYE vs. The Competition Export to ExcelMetricNational VisionCONS PD IndustryStaples SectorNASDAQ ExchangeMarket Cap$2.13B$32.80B$15.94B$10.46BDividend YieldN/A2.60%3.06%4.57%P/E Ratio-147.7837.6517.8026.86Price / Sales1.161.8652.28125.65Price / Cash16.4616.5314.8631.15Price / Book2.578.267.446.50Net Income-$28.50M$1.23B$674.86M$271.25M7 Day Performance10.69%-1.53%0.19%3.27%1 Month Performance7.13%-3.42%1.26%8.15%1 Year Performance150.71%18.91%-1.78%26.52% National Vision Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)EYENational Vision2.2333 of 5 stars$26.60-1.2%$24.73-7.0%+151.4%$2.13B$1.82B-147.7813,411NVSTEnvista3.7762 of 5 stars$21.12+0.5%$20.92-0.9%+10.0%$3.49B$2.51B65.9912,300Positive NewsIRTCiRhythm Technologies1.1463 of 5 stars$176.16-2.0%$163.82-7.0%+163.9%$5.78B$657.23M-60.122,000Positive NewsBLCOBausch + Lomb1.8667 of 5 stars$15.23+0.2%$15.56+2.2%-23.5%$5.38B$4.79B-19.5213,500GKOSGlaukos4.7051 of 5 stars$80.72-2.5%$124.83+54.6%-33.7%$4.75B$383.48M-48.92780Positive NewsAnalyst ForecastTMDXTransMedics Group2.0757 of 5 stars$114.29-0.2%$122.11+6.8%-24.2%$3.91B$441.54M59.22210LIVNLivaNova2.7486 of 5 stars$55.43-1.4%$59.71+7.7%+8.6%$3.07B$1.25B-14.252,900Positive NewsSLNOSoleno Therapeutics4.4414 of 5 stars$51.17-4.6%$115.09+124.9%+9.6%$2.85BN/A-12.3630WRBYWarby Parker1.4553 of 5 stars$26.37-1.4%$24.06-8.8%+100.2%$2.81B$771.32M-376.723,780INSPInspire Medical Systems4.8447 of 5 stars$80.90+1.1%$164.50+103.3%-62.9%$2.37B$802.80M46.761,246Analyst DowngradeGap DownLQDALiquidia Technologies3.9451 of 5 stars$26.77+3.0%$32.11+20.0%+130.2%$2.24B$14M-15.7550 Related Companies and Tools Related Companies NVST Alternatives IRTC Alternatives BLCO Alternatives GKOS Alternatives TMDX Alternatives LIVN Alternatives SLNO Alternatives WRBY Alternatives INSP Alternatives LQDA Alternatives Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:EYE) was last updated on 9/23/2025 by MarketBeat.com Staff From Our PartnersTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredHe Called Nvidia at $1.10. Now, He Says THIS Stock Will…The original Magnificent Seven returned 16,894%—turning $7K into $1.18 million. Now, the man who called Nvi...The Oxford Club | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredA New Way to Double Your Retirement Income?Bloomberg reports that a new class of investments is “entering a golden era,” with yields fueling a retail boo...Investors Alley | SponsoredForget NVDA. Put $1,000 into this stock nowA massive money shift is underway in the AI market. And it's opening up an extraordinary opportunity in a NEW ...Chaikin Analytics | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredTrump's Law S.1582: $21T Dollar Revolution ComingDo you have money in any of these banks? Chase. Bank of America. Citigroup. Wells Fargo. U.S. Bancorp. I...Brownstone Research | SponsoredCrypto Gets Official Government Backing—Here's the WinnerTrump Just Signed the GENIUS Act—One Coin is About to Explode We're at the BEGINNING of smart money really ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding National Vision Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share National Vision With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.